17-02-2025
South Korea Flow Cytometry Industry Trends, Key Players & Future Outlook: Rising Healthcare & Biotech Investments Drive South Korea Flow Cytometry Market Growth
Competitive Landscape & Industry Leaders: Key players such as Becton, Dickinson and Company, Thermo Fisher Scientific, and Danaher Corporation are shaping the market with cutting-edge innovations and strategic collaborations.
South Korean Flow Cytometry Market
Dublin, Feb. 17, 2025 (GLOBE NEWSWIRE) -- The "South Korea Flow Cytometry Market: Analysis and Forecast, 2024-2033" report has been added to cytometry has emerged as a transformative technology in South Korea, driven by advancements in research and industrial applications. This versatile technology enables high-throughput analysis of single cells, offering applications ranging from clinical diagnostics to industrial biotechnology. South Korea's commitment to innovation and R&D investments has catalyzed the adoption of flow cytometry, with significant contributions from key players like Becton, Dickinson and Company, Danaher Corporation (Beckman Coulter), and Thermo Fisher Scientific Inc. Despite challenges such as high costs and technological complexity, the growth trajectory of flow cytometry in South Korea is promising, supported by government initiatives and increasing healthcare and biotech South Korean flow cytometry market was valued at $82.12 million in 2024 and is projected to reach $244.49 million by 2033, growing at a CAGR of 12.89% during the forecast period (2024-2033). Investments in flow cytometry in the country saw a significant year-on-year increase of 23.23% from $431.3 million in 2020 to $531.5 million in 2021. This upward trend reflects the growing importance of this technology across clinical, research, and industrial domains.
Recent Developments:
Industrial-Scale Developments
January 2024: SML Meditree partnered with Sengenics to distribute its immune proteomics platform, KREX, in South Korea.
February 2022: IDEXX Laboratories launched the Procyte One analyzer in South Korea, leveraging advanced flow cytometry laser technology.
Research-Scale Developments
August 2023: Seoul St. Mary's Hospital researchers received recognition for their work on MRD monitoring using multi-parametric flow cytometry.
January 2023: Expansion of Eunpyeong St. Mary's Hospital to enhance its analytical capabilities, including additional flow cytometers.
These developments highlight the expanding role of flow cytometry in both research and clinical settings within South Demand Drivers and Limitations
The following are the demand drivers for South Korea flow cytometry market:
Increasing Healthcare Investments and Biotechnology and Pharmaceutical Manufacturing in South Korea
Increasing Research and Development Expenditure in the Country
The market is expected to face some limitations due to the following challenges:
High Cost of Acquisition
The South Korean flow cytometry market is poised for substantial growth, underpinned by increasing investments in healthcare and biotechnology, advancements in technology, and expanding applications in diagnostics and research. Despite challenges such as high costs and reliance on imports, opportunities in automation, AI integration, and emerging clinical applications position South Korea as a key player in the global flow cytometry landscape. Strategic collaborations and adherence to stringent regulatory standards will further bolster the market's trajectory over the next Strategy:
A detailed competitive benchmarking of the players operating in the South Korea flow cytometry market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Players in the South Korea Flow Cytometry Market profiled in the report include:
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Cytek Biosciences, Inc.
Danaher Corporation (Beckman Coulter)
II-VI Incorporated
Sony Group Corporation (Sony Biotechnology)
Sysmex Corporation
Thermo Fisher Scientific Inc.
Miltenyi Biotec
Key Attributes:
Report Attribute
Details
No. of Pages
108
Forecast Period
2024 - 2033
Estimated Market Value (USD) in 2024
$82.12 Million
Forecasted Market Value (USD) by 2033
$244.49 Million
Compound Annual Growth Rate
12.8%
Regions Covered
South Korea
Key Topics Covered: 1 Market Overview1.1 Introduction1.2 Market Footprint1.2.1 Major Flow Cytometry Systems1.2.2 Market Penetration of Flow Cytometry1.2.3 Recent Developments1.2.4 SWOT Analysis1.3 Regulatory Compliance1.4 Technology Landscape2 Market Dynamics2.1 Impact Analysis2.2 Market Drivers2.2.1 Increasing Healthcare Investments and Biotechnology and Pharmaceutical Manufacturing in South Korea2.2.2 Increasing Research and Development Expenditure in the Country2.3 Market Restraints2.3.1 High Cost of Acquisition2.4 Market Opportunities2.4.1 Increasing Use of Automation in Flow Cytometry Laboratories3 Product Mapping3.1 Instrument Product Mapping Analysis3.2 Consumable Product Mapping Analysis3.3 Imagin System and Software Product Mapping Analysis4 Competitive Insights4.1 Product Launches4.2 Expansion4.3 Increasing Awareness4.4 Market Share Analysis (by Company)4.5 Growth-Share Matrix5 South Korea Flow Cytometry Market, by Product5.1 Overview5.2 Instruments5.2.1 Key Players5.2.2 Platforms5.2.3 Replaceable Components and Accessories5.3 Reagents and Consumables5.3.1 Key Players5.3.2 Antibodies5.3.3 Fluorescent Dye5.3.4 Beads5.3.5 Others5.4 Imaging Systems and Software6 South Korea Flow Cytometry Market, by Method6.1 Overview6.2 Bead-based Flow Cytometry6.3 Cell-based Flow Cytometry7 South Korea Flow Cytometry Market, by Application7.1 Overview7.2 Clinical Applications7.2.1 Cancer7.2.2 Hematology7.2.3 Autoimmune Diseases7.2.4 Organ Transplantation7.2.5 Others7.3 Research Applications7.3.1 Drug Discovery7.3.2 Stem Cell Research7.3.3 In-Vitro Toxicology Testing7.3.4 Biomarker Detection7.3.5 Cell Apoptosis7.3.6 Cell Cycle Analysis7.3.7 Cell Viability7.3.8 Others7.4 Industrial Applications7.4.1 Food and Beverages7.4.2 Water Treatment7.4.3 Microbiology Testing7.4.4 Cosmetics and Personal Care Industry7.4.5 Agriculture and Fermentation Industry7.4.6 Other Industries<8 South Korea Flow Cytometry Market, by End Users8.1 Overview8.2 Academic and Research Institutes8.3 Hospitals and Clinical Testing Laboratories8.4 Pharmaceutical and Biotechnology Companies8.5 Industrial Companies8.6 Others9 Company Profiles
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Cytek Biosciences, Inc.
Danaher Corporation (Beckman Coulter)
II-VI Incorporated
Sony Group Corporation (Sony Biotechnology)
Sysmex Corporation
Thermo Fisher Scientific Inc.
Miltenyi Biotec
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
South Korean Flow Cytometry Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
